A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 801–900 of 1,000
Why the Discrepancy Between Antidepressant Drug Use and Evidence Base in Bipolar Disorder?
Post, R. M. (2014) · Future Neurology · doi:10.2217/fnl.14.19
Lamotrigine for Pediatric Patients with Epilepsy
Biton, V. (2008) · Pediatric Health · doi:10.2217/17455111.2.2.125
Perspectives on the pharmacological treatment of bipolar disorder
Soares, J. C. (2002) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462002000300002
Head-to-Head comparison of olanzapine/fluoxetine combination and lamotrigine in bipolar I depression
Thase, M. E. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0054-7
Benkert, O., Hautzinger, M., Graf-Morgenstern, M., Paulzen, M., & Himmerich, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-49092-1_15
Trial-Based Advances in the Treatment of Bipolar Depression
Kemp, D. E., Gao, K., Muzina, D. J., Gajwani, P., & Calabrese, J. R. (2006) · Progress in Neurotherapeutics and Neuropsychopharmacology · doi:10.1017/s1748232106000140
Self-citationLamotrigine for bipolar I disorder improved depressive symptoms on some depression scales
Haslam, D. B. (1999) · Evidence-Based Mental Health · doi:10.1136/ebmh.2.3.75
DRUGS ON ELECTROPHYSIOLOGICAL PROPERTIES OF CA1 NEURONS IN HIPPOCAMPUS
Englund, M. (2007)
Introduction to assessment in depression
Kasper, S. F., & Möller, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-04627-3_1
Papel dos canais de sódio voltagem dependentes no efeito antidepressivo da lamotrigina
Codagnone, F. T. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
EFEITO ANTIDEPRESSIVO DA LAMOTRIGINA NO MODELO DE NATAÇÃO FORÇADA MODIFICADO EM RATOS
Consoni, F. T. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Nierenberg, A. A., Friedman, E. S., Bowden, C. L., Sylvia, L. G., Thase, M. E., Ketter, T. A., Ostacher, M. J., Leon, A. C., Reilly-Harrington, N. A., Iosifescu, D. V., et al. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130116
Self-citationA PRIMARY CARE APPROACH TO BIPOLAR DISORDER
Kaye, N. (2006)
Poore, A. B. (2010)
Bibliography: Bipolar Disorder
(2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.4.foc466
La Quetiapina nel trattamento della depressione bipolare
Camilleri, V., & Mauri, M. C. (2005) · CINECA IRIS Institutial research information system (University of Pisa)
Lamotrigina: Evidencia de su utilidad en el trastorno bipolar
Amado, A. P. (2001) · Medunab
Anticonvulsants in Neuropsychiatry
Gaviria, M., & Medina, D. (2001) · Springer eBooks · doi:10.1007/978-4-431-67897-7_63
The specificity of platelet glutamate receptor sensitivity as a putative marker for schizophrenia
Belsham, B. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
I cicli rapidi nel disturbo bipolare
Perugi, G., & Restuccia, G. (2005) · CINECA IRIS Institutial research information system (University of Pisa)
Diagnosis and Pharmacological Treatment of Bipolar Depression: A Case Example
Bailey, K. P. (2002) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-20020801-11
Maj, M. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200304002-00012
Therapeutic Approaches to Bipolar Disorder
Ahmad, M. U., Ali, S. M., Sheikh, S., Ahmad, A., & Ahmad, I. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00333
Behandlung depressiver Störungen
Schmauß, M., & Messer, T. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_1
Bibliography for Bipolar Disorder
(2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.1.32
Something Borrowed, Something Blue:Why is Bipolar Disorder an Orphan?
Nierenberg, A. A. (2010) · CNS Spectrums · doi:10.1017/s1092852900000250
Antiepileptic Drugs in the Treatment of Psychiatric Diseases
Kanner, A. M., & Palac, S. M. (2001) · Springer eBooks · doi:10.1007/978-4-431-67897-7_64
AVANCES EN PSICOFARMACOLOGÍA Lamotrigina en psiquiatría
Asins, J. C., Montalbán, S. R., & Martínez, A. (2016)
Pharmacologic and somatic treatments for bipolar depression
Giner, L., Kelly, S. A., & Oquendo, M. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.007
The role of anticonvulsants as mood stabilizers
Bowden, C. L. (2001) · The Journal of Clinical Psychiatry · Cited by 1
Self-citation34 Psychopharmacology and Other Somatic Therapies
Perry, P. J., Wehring, H. J., ALEXANDER, B. K., & Liskow, B. I. (2008)
Bipolar affective disorder: advances in genetics and mood-stabilising medication
White, D. C., & Kelly, B. D. (2006) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700009423
Carpenter, L. L., Philip, N. S., & O’Reardon, J. P. (2009) · Medical psychiatry · doi:10.3109/9781420084887.009
Kasper, S. F. (2006) · European Neurological Review · doi:10.17925/enr.2006.00.01.77
DEPRESSION AND BIPOLAR DISORDERS
Berrettini, W. H. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50057-3
Hovens, J. E., & LOONEN, A. J. M. (2006) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-9244-5_3
A factor analytic study in bipolar depression, and response to lamotrigine
Mitchell, P. B., Malhi, G. S., & Hadži-Pavlović, D. (2006) · Acta Neuropsychiatrica · doi:10.1017/s0924270800030581
Role of Antiepileptic Drugs in the Treatment ofMajor Depressive Disorder
Nelson, E. B. (2008) · Medical psychiatry · doi:10.3109/9780849382666.010
Psychopharmacology of mood disorders
Coryell, W. H., & Geddes, J. R. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.029
Antidepressant Effect of Mood Stabilizers
Baldassano, C. F. (2003) · CNS Spectrums · doi:10.1017/s1092852900028777
Traitement pharmacologique des dépressions bipolaires
THUILE, J., EVEN, C., & Guelfi, J. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76229-7
Shim, S. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6173
Neuropsychiatric Aspects of Traumatic Brain Injury: Symptoms and Pharmacotherapy
Choi, J.-Y., & Nam, B. (2009) · 대한정신약물학회지
Samalin, L. (2016) · theses.fr (ABES) · doi:10.70675/1dcbf76dza50bz4094za139z88296ad7a689 · Cited by 4
Progress in the Treatment of Bipolar Depression: Advances and Challenges
Kemp, D. E., Gao, K., Muzina, D. J., & Calabrese, J. R. (2006) · The Psychiatric times
Self-citationThe Investigation for Lamotrigine Prescription in Dazaifu Hospital
Nuki, K., Ogyu, S., Usami, T., Wasano, S., Takei, H., Hasuzawa, S., Yoshimura, M., Jinbo, S., Ohashi, A., Sasaki, K., et al. (2015) · Kyushu Neuropsychiatry · doi:10.11642/kyushuneurop.61.1_14
González, M. L. (2005) · Louisiana State University · doi:10.31390/gradschool_theses.364
Valle, L. P. (2017) · Louisiana State University · doi:10.31390/gradschool_theses.4565
Myczkowski, M. L. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-02082018-100807
Bipolar Disorder: Increasing the Effectiveness and Decreasing the Side Effects of Treatment
Jensen, B., Nguyen, C. T., & Maguire, G. A. (2007)
Bipolare Störungen (ICD-10 F3)
Schläpfer, T. E., WINKLER, R., Greil, W., & GIERSCH, D. (2007) · Elsevier eBooks · doi:10.1016/b978-343724131-4.50013-5
Nuevos anticonvulsivantes en la profilaxis del trastorno bipolar
de Heredia, J. L. L. (2003) · European psychiatry (Ed Española) · doi:10.1017/s113406650000789x
McGrath, B. M. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v8i1.517
Lamotrigine Monotherapy for Bipolar Depression
TUCKER, G. J. (1999) · Journal watch · doi:10.1056/jp199905010000009
Romano, R. M., & Védova, C. O. D. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.009
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg002
Lewitzka, U. (2014) · doi:10.2217/ebo.13.646
(2006) · CRC Press eBooks · doi:10.3109/9780203490754-7
Lam, D. H., Jones, S. H., & Hayward, P. (2010) · Wiley eBooks · doi:10.1002/9780470970256.refs
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt064
Walden, J., Grunze, H., Dose, M., & Emrich, H. M. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_13
Schmitz, M. (2004) · Steinkopff eBooks · doi:10.1007/978-3-7985-1927-5_4
Polypharmazie in der Behandlung depressiver Störungen
Schmauß, M., & Messer, T. (2006) · Springer eBooks · doi:10.1007/3-211-31221-8_1
(2005) · CRC Press eBooks · doi:10.1201/b14455-4
Bschor, T., & Bauer, M. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_26
Denko, T., & Thase, M. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_24
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.058
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.051
Pharmacological Treatment of Acute Bipolar Depression
Sachs, G. S. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_9
Self-citationStahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.007
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0112
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.008
Aldenkamp, A. P. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.334024.x
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372997.as05
Frye, M. A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.023
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.097
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0138
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.082
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.074
Seemüller, F., & Grunze, H. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_21
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0145
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.093
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.028
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0108
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0130
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.026
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.029
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0122
Reply to A Different Mechanism to Understand Activation/Sedation Side Effects of Ziprasidone
Stahl, S. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624g
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0107
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.035
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.015
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.0150
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.044
Ostacher, M. J., & Tilley, C. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50050-0
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.001
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.